PhytoGeniX Overview
- Founded
- 2000
- Status
- Private
- Latest Deal Type
- Early Stage VC
- Investors
- 1
PhytoGeniX General Information
Description
Provider of medicinal research services intended to develop phytomedicines and phytogenic drugs. The company's services offer the development of new phytomedicines, lead finding, and optimization as well as offers efficacy testing of phytomedicines, herbal extracts, and isolated constituents, thereby enabling clients to evaluate biological activity and control moss.
Contact Information
Website
www.phytogenix.nl
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
- Regulierenring 9
- 3981 LA Bunnik
- Netherlands
+31 06 00000000
PhytoGeniX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jan-2000 | Completed | Startup |
PhytoGeniX Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Kees Beukelman Ph.D | Chief Executive Officer & Co-Founder | ||
| Bert Van den Berg Ph.D | Owner |
PhytoGeniX Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Utrecht Holdings | Venture Capital | Minority | 000 0000 | 000000 0 |